Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer

被引:13
|
作者
Li, Hui [1 ,2 ,3 ]
Shi, Wei [1 ,2 ,3 ]
Shen, Tingming [4 ]
Hui, Siwen [2 ,3 ]
Hou, Manting [2 ,3 ]
Wei, Ziying [1 ,2 ,3 ]
Qin, Shuanglin [5 ]
Bai, Zhaofang [2 ,3 ]
Cao, Junling [1 ,6 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 102488, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Hepatol, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, China Mil Inst Chinese Mat, Med Ctr 5, Beijing, Peoples R China
[4] Ningde Hosp Tradit Chinese Med, Ningde, Peoples R China
[5] Hubei Univ Sci & Technol, Xianning Med Coll, Sch Pharm, Xianning, Peoples R China
[6] Beijing Univ Chinese Med, Dongzhimen Hosp, Luoyang Branch, Beijing, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
breast cancer; Ecliptae Herba; molecular docking; network pharmacology; TGF-beta; 1; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; STEM-CELLS; TGF-BETA; METASTASIS; RESOURCE; EXTRACT;
D O I
10.1097/MD.0000000000035384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer is a prevalent malignancy affecting women globally, characterized by significant morbidity and mortality rates. Ecliptae Herba is a traditional herbal medicine commonly used in clinical practice, has recently been found to possess antitumor properties. In order to explore the underlying material basis and molecular mechanisms responsible for the anti-breast cancer effects of Ecliptae Herba, we used network pharmacology and experimental verification. UPLC-MS/MS was utilized to identify compounds present in Ecliptae Herba. The active components of Ecliptae Herba and its breast cancer targets were screened using public databases. Hub genes were identified using the STRING and Metascape database. The R software was utilized for visual analysis of GO and KEGG pathways. The affinity of the hub targets for the active ingredients was assessed by molecular docking analysis, which was verified by experimental assessment. A total of 178 targets were obtained from the 10 active components of Ecliptae Herba, while 3431 targets associated with breast cancer were screened. There were 144 intersecting targets between the components and the disease. Targets with a higher degree, namely EGFR and TGFB1, were identified through the hub subnetwork of PPI. GO and KEGG analyses revealed that Ecliptae Herba plays an important role in multiple cancer therapeutic mechanisms. Moreover, molecular docking results showed that the core components had good binding affinity with key targets. Finally, it was confirmed that TGF-beta 1 might be a potential crucial target of Ecliptae Herba in the treatment of breast cancer by cytological experiments, and the TGF-beta 1/Smad signaling pathway might be an important pathway for Ecliptae Herba to exert its therapeutic effects. This study elucidated the active ingredients, key targets, and molecular mechanisms of Ecliptae Herba in the treatment of breast cancer, providing a scientific foundation and therapeutic mechanism for the prevention and treatment of breast cancer with Traditional Chinese medicine.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Prediction of potential cancer-related molecular targets of North African plants constituents using network pharmacology-based analysis
    Shawky, Eman
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 238
  • [22] A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer
    Qayoom, Hina
    Alkhanani, Mustfa
    Almilaibary, Abdullah
    Alsagaby, Suliman A.
    Mir, Manzoor A.
    MEDICAL ONCOLOGY, 2023, 40 (07)
  • [23] Network Pharmacology-Based Prediction and Experimental Validation of the Targets and Mechanism of Tilianin Action Against Myocardial Infarction
    Li, Xiaojing
    Li, Ning
    Yang, Xiaoyi
    Zeng, Cheng
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2023, 21 (02) : 150 - 158
  • [24] A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer
    Hina Qayoom
    Mustfa Alkhanani
    Abdullah Almilaibary
    Suliman A. Alsagaby
    Manzoor A. Mir
    Medical Oncology, 40
  • [25] Network pharmacology-based strategy to investigate the bioactive ingredients and molecular mechanism of Evodia rutaecarpa in colorectal cancer
    Yongqu Lu
    Kangdi Dong
    Meng Yang
    Jun Liu
    BMC Complementary Medicine and Therapies, 23
  • [26] Network pharmacology-based strategy to investigate the bioactive ingredients and molecular mechanism of Evodia rutaecarpa in colorectal cancer
    Lu, Yongqu
    Dong, Kangdi
    Yang, Meng
    Liu, Jun
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [27] Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma
    Wang, Chunpeng
    Liu, Xiaohui
    Guo, Shiwen
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [28] Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
    Guohua Yu
    Wubin Wang
    Xu Wang
    Meng Xu
    Lili Zhang
    Lei Ding
    Rui Guo
    Yuanyuan Shi
    BMC Complementary and Alternative Medicine, 18
  • [29] Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
    Yu, Guohua
    Wang, Wubin
    Wang, Xu
    Xu, Meng
    Zhang, Lili
    Ding, Lei
    Guo, Rui
    Shi, Yuanyuan
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
  • [30] Network pharmacology-based study to identify the significant pathways of Lentinula edodes against cancer
    Oh, Ki Kwang
    Adnan, Md
    Cho, Dong Ha
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (09)